Table 1. Clinical and biochemical characteristics of ALS patients and control subjects.
ITEMS | Control | ALS | |
---|---|---|---|
Cohort size | 48 | 48 | |
Gender ratio (F/M) | 18/30 | 18/30 | |
Age at collection (years) | 54.1 [31.7–66.6] | 54.9 [34.9–68.7] | |
Duration (days) | N/A | 809 ± 75.3 | |
ALSFRS-R (score) | N/A | 29.8 ± 1.3 | |
Site at onset (bulbar/spinal) | N/A | 14/35 | |
BMI (kg/m²) | N/A | 23.6 ± 0.6 | |
Triglycerides (g/L) | 1.24 ± 0.1 | 1.44 ±0.1 | |
Total cholesterol (g/L) | 2.60 ± 0.2 | 2.54 ± 0.2 | |
Free fatty acid (mM) | 0.12 ± 0.0 | 0.27 ± 0.1 | * |
Leptin (ng/mL) | 9.66 ± 1.5 | 6.11 ± 0.9 | * |
*p<0.05 (Mann-Withney test).